BRENDA KELLEY: Open Payments
NPI 1861888414 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 27 payments from 13 companies in 2025. Trend: 2023 $14 · 2024 $100 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $463 |
| CSL Behring | 2 | $50 |
| GENZYME CORPORATION | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| PFIZER INC. | 2 | $33 |
| Incyte Corporation | 1 | $27 |
| Cycle Pharmaceuticals Inc | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Blueprint Medicines Corporation | 1 | $18 |
| Pharming Healthcare, Inc. | 1 | $17 |
Products named: AIRSUPRA, TEZSPIRE, FASENRA, Andembry, DUPIXENT, TAKHZYRO, PAXLOVID, OPZELURA.
Industry payments across OK — which companies pay providers there.
